Cav2.2

1

Berecki G et al. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
Neuropharmacology, 2016 May 28 , 109 (49-58).

2

Gafar H et al. Membrane coordination of receptors and channels mediating the inhibition of neuronal ion currents by ADP.
Purinergic Signal., 2016 May 12 , ().

3

Berecki G et al. Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits.
Mol. Pharmacol., 2016 Jan , 89 (187-96).

4

Castro J et al. α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors.
Gut, 2016 Feb 17 , ().

5

Ferron L Fragile X mental retardation protein controls ion channel expression and activity.
J. Physiol. (Lond.), 2016 Feb 10 , ().

6

Bragança B et al. Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria.
Front Pharmacol, 2016 , 7 (45).

7

Ye F et al. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
Toxins (Basel), 2016 , 8 ().

8

Lu VB et al. Strategies for Investigating G-Protein Modulation of Voltage-Gated Ca2+ Channels.
Cold Spring Harb Protoc, 2016 , 2016 (pdb.top087072).

9

Lazcano-Pérez F et al. Activity of Palythoa caribaeorum Venom on Voltage-Gated Ion Channels in Mammalian Superior Cervical Ganglion Neurons.
Toxins (Basel), 2016 , 8 ().

10

Chang CY et al. Apigenin, a natural flavonoid, inhibits glutamate release in the rat hippocampus.
Eur. J. Pharmacol., 2015 Sep 5 , 762 (72-81).

11

Mencacci NE et al. The CACNA1B R1389H variant is not associated with myoclonus-dystonia in a large European multicentric cohort.
Hum. Mol. Genet., 2015 Sep 15 , 24 (5326-9).

12

Kim DI et al. Molecular Basis of the Membrane Interaction of the β2e Subunit of Voltage-Gated Ca(2+) Channels.
Biophys. J., 2015 Sep 1 , 109 (922-35).

13

Takada Y et al. Rab3 interacting molecule 3 mutations associated with autism alter regulation of voltage-dependent Ca²⁺ channels.
Cell Calcium, 2015 Sep , 58 (296-306).

14

Kumar D et al. Cacna1c (Cav1.2) Modulates Electroencephalographic Rhythm and Rapid Eye Movement Sleep Recovery.
Sleep, 2015 Sep , 38 (1371-80).

15

López Soto EJ et al. Constitutive and ghrelin-dependent GHSR1a activation impairs CaV2.1 and CaV2.2 currents in hypothalamic neurons.
J. Gen. Physiol., 2015 Sep , 146 (205-19).

16

Butler MG et al. Currently recognized genes for schizophrenia: High-resolution chromosome ideogram representation.
Am. J. Med. Genet. B Neuropsychiatr. Genet., 2015 Oct 13 , ().

17

Park SJ et al. Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.
Biochim. Biophys. Acta, 2015 Oct , 1848 (2092-100).

18

Rousset M et al. Regulation of neuronal high-voltage activated Ca(V)2 Ca(2+) channels by the small GTPase RhoA.
Neuropharmacology, 2015 Oct , 97 (201-9).

19

Tisarum R et al. Uptake of antimonite and antimonate by arsenic hyperaccumulator Pteris vittata: Effects of chemical analogs and transporter inhibitor.
Environ. Pollut., 2015 Nov , 206 (49-55).

20

Chang Y et al. Myricetin inhibits the release of glutamate in rat cerebrocortical nerve terminals.
J Med Food, 2015 May , 18 (516-23).

21

Ament SA et al. Rare variants in neuronal excitability genes influence risk for bipolar disorder.
Proc. Natl. Acad. Sci. U.S.A., 2015 Mar 17 , 112 (3576-81).

22

Zhou FJ et al. Two New Classes of T-Type Calcium Channel Inhibitors with New Chemical Scaffolds from Ganoderma cochlear.
Org. Lett., 2015 Jun 19 , 17 (3082-5).

23

Plourde M et al. Generation of an aquaglyceroporin AQP1 null mutant in Leishmania major.
Mol. Biochem. Parasitol., 2015 Jun , 201 (108-11).

24

Weiss N The first disease connection for Cav2.2 channels.
Gen. Physiol. Biophys., 2015 Jul , 34 (217-9).

25

François-Moutal L et al. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
Pain, 2015 Jul , 156 (1247-64).

26

Liu F et al. 14-3-3τ promotes surface expression of Cav2.2 (α1B) Ca2+ channels.
J. Biol. Chem., 2015 Jan 30 , 290 (2689-98).

27

Naranjo D et al. Zebrafish CaV2.1 calcium channels are tailored for fast synchronous neuromuscular transmission.
Biophys. J., 2015 Feb 3 , 108 (578-84).

28

Groen JL et al. CACNA1B mutation is linked to unique myoclonus-dystonia syndrome.
Hum. Mol. Genet., 2015 Feb 15 , 24 (987-93).

29

Huynh TG et al. Novel mechanism of voltage-gated N-type (Cav2.2) calcium channel inhibition revealed through α-conotoxin Vc1.1 activation of the GABA(B) receptor.
Mol. Pharmacol., 2015 Feb , 87 (240-50).

30

Zhou MH et al. Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation.
J. Biol. Chem., 2015 Dec 18 , 290 (30616-23).

31

Zhang S et al. ZC88, a novel N-type calcium channel blocker from 4-amino-piperidine derivatives state-dependent inhibits Cav2.2 calcium channels.
Brain Res., 2015 Apr 24 , 1605 (12-21).

32

D'Arco M et al. The upregulation of α2δ-1 subunit modulates activity-dependent Ca2+ signals in sensory neurons.
J. Neurosci., 2015 Apr 15 , 35 (5891-903).

33

Gleeson EC et al. Inhibition of N-type calcium channels by fluorophenoxyanilide derivatives.
Mar Drugs, 2015 Apr , 13 (2030-45).

34

Zhu L et al. "Slow" Voltage-Dependent Inactivation of CaV2.2 Calcium Channels Is Modulated by the PKC Activator Phorbol 12-Myristate 13-Acetate (PMA).
PLoS ONE, 2015 , 10 (e0134117).

35

Buraei Z et al. Single channel measurements demonstrate the voltage dependence of permeation through N-type and L-type CaV channels.
Channels (Austin), 2015 , 9 (50-5).

36

Wang CY et al. Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients.
PLoS ONE, 2015 , 10 (e0125766).

37

Fernández-Morales JC et al. Hypoxia-elicited catecholamine release is controlled by L-type as well as N/PQ types of calcium channels in rat embryo chromaffin cells.
Am. J. Physiol., Cell Physiol., 2014 Sep 1 , 307 (C455-65).

38

Yamada Y et al. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
Cardiovasc. Res., 2014 Oct 1 , 104 (183-93).

39

Keum D et al. Voltage-dependent regulation of CaV2.2 channels by Gq-coupled receptor is facilitated by membrane-localized β subunit.
J. Gen. Physiol., 2014 Oct , 144 (297-309).

40

Lin TY et al. Cyclooxygenase 2 inhibitor celecoxib inhibits glutamate release by attenuating the PGE2/EP2 pathway in rat cerebral cortex endings.
J. Pharmacol. Exp. Ther., 2014 Oct , 351 (134-45).

41

Felizola SJ et al. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
J. Steroid Biochem. Mol. Biol., 2014 Oct , 144 Pt B (410-6).

42

Rajagopal S et al. Inhibition of protein kinase C (PKC) response of voltage-gated calcium (Cav)2.2 channels expressed in Xenopus oocytes by Cavβ subunits.
Neuroscience, 2014 Nov 7 , 280 (1-9).

43

Weiss J et al. Altered synaptic transmission at olfactory and vomeronasal nerve terminals in mice lacking N-type calcium channel Cav2.2.
Eur. J. Neurosci., 2014 Nov , 40 (3422-35).

44

Gandini MA et al. CaV2.2 channel cell surface expression is regulated by the light chain 1 (LC1) of the microtubule-associated protein B (MAP1B) via UBE2L3-mediated ubiquitination and degradation.
Pflugers Arch., 2014 Nov , 466 (2113-26).

45

Li DP et al. Nitric oxide stimulates glutamatergic synaptic inputs to baroreceptor neurons through potentiation of Cav2.2-mediated Ca(2+) currents.
Neurosci. Lett., 2014 May 1 , 567 (57-62).

46

Winters MP et al. Discovery and SAR of novel tetrahydropyrrolo[3,4-c]pyrazoles as inhibitors of the N-type calcium channel.
Bioorg. Med. Chem. Lett., 2014 May 1 , 24 (2053-6).

47

Winters MP et al. Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitors.
Bioorg. Med. Chem. Lett., 2014 May 1 , 24 (2057-61).

48

Zoidis G et al. Anti-allodynic effect of 2-(aminomethyl)adamantane-1-carboxylic acid in a rat model of neuropathic pain: a mechanism dependent on CaV2.2 channel inhibition.
Bioorg. Med. Chem., 2014 Mar 15 , 22 (1797-803).

49

Kuryshev YA et al. Evaluating state dependence and subtype selectivity of calcium channel modulators in automated electrophysiology assays.
Assay Drug Dev Technol, 2014 Mar , 12 (110-9).

50

Coleman N et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1.
Mol. Pharmacol., 2014 Jun 23 , ().

51

Cassidy JS et al. Functional exofacially tagged N-type calcium channels elucidate the interaction with auxiliary α2δ-1 subunits.
Proc. Natl. Acad. Sci. U.S.A., 2014 Jun 17 , 111 (8979-84).

52

Ricoy UM et al. Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics.
J. Neurophysiol., 2014 Jun 15 , 111 (2404-13).

53

Duan JH et al. N-type calcium current, Cav2.2, is enhanced in small-diameter sensory neurons isolated from Nf1+/- mice.
Neuroscience, 2014 Jun 13 , 270 (192-202).

54

Wang CC et al. Dimebon, an antihistamine drug, inhibits glutamate release in rat cerebrocortical nerve terminals.
Eur. J. Pharmacol., 2014 Jul 5 , 734 (67-76).

55

Saegusa H et al. N-type voltage-dependent Ca2+ channel in non-excitable microglial cells in mice is involved in the pathophysiology of neuropathic pain.
Biochem. Biophys. Res. Commun., 2014 Jul 18 , 450 (142-7).

56

Berecki G et al. Effects of arginine 10 to lysine substitution on ω-conotoxin CVIE and CVIF block of Cav2.2 channels.
Br. J. Pharmacol., 2014 Jul , 171 (3313-27).

57

Ruchala I et al. Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels.
Cell Calcium, 2014 Jul , 56 (25-33).

58

Kline CF et al. Ankyrin-B regulates Cav2.1 and Cav2.2 Expression and Targeting.
J. Biol. Chem., 2014 Jan 6 , ().

59

Satake S et al. Cav2.1 channels control multivesicular release by relying on their distance from exocytotic Ca2+ sensors at rat cerebellar granule cells.
J. Neurosci., 2014 Jan 22 , 34 (1462-74).

60

Fischer G et al. Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion.
Gene Ther., 2014 Jan , 21 (44-51).

61

Hernández-Castellanos JM et al. Gβ₂ mimics activation kinetic slowing of CaV2.2 channels by noradrenaline in rat sympathetic neurons.
Biochem. Biophys. Res. Commun., 2014 Feb 28 , 445 (250-4).

62

Halling DB et al. Calcium-dependent stoichiometries of the KCa2.2 (SK) intracellular domain/calmodulin complex in solution.
J. Gen. Physiol., 2014 Feb , 143 (231-52).

63

Swensen AM et al. Characterization of the triazine, T4, a representative from a novel series of CaV2 inhibitors with strong state-dependence, poor use-dependence, and distinctively fast kinetics.
Eur. J. Pharmacol., 2014 Dec 15 , 745 (234-42).

64

Chhabra S et al. Dicarba analogues of α-conotoxin RgIA. Structure, stability, and activity at potential pain targets.
J. Med. Chem., 2014 Dec 11 , 57 (9933-44).

65

Li L et al. Potentiation of high voltage-activated calcium channels by 4-aminopyridine depends on subunit composition.
Mol. Pharmacol., 2014 Dec , 86 (760-72).

66

Ronzitti G et al. Exogenous α-synuclein decreases raft partitioning of Cav2.2 channels inducing dopamine release.
J. Neurosci., 2014 Aug 6 , 34 (10603-15).

67

Davydova D et al. Bassoon specifically controls presynaptic P/Q-type Ca(2+) channels via RIM-binding protein.
Neuron, 2014 Apr 2 , 82 (181-94).

68

Berecki G et al. Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation.
J. Gen. Physiol., 2014 Apr , 143 (465-79).

69

Gandini MA et al. The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels.
Channels (Austin), 2014 , 8 (452-7).

70

Lin TY et al. Acacetin inhibits glutamate release and prevents kainic acid-induced neurotoxicity in rats.
PLoS ONE, 2014 , 9 (e88644).

71

Ju W et al. SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons.
Channels (Austin), 2013 May-Jun , 7 (153-9).

72

Patel R et al. α2δ-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage.
J. Neurosci., 2013 Oct 16 , 33 (16412-26).

73

Ramachandra R et al. Identification of CaV channel types expressed in muscle afferent neurons.
J. Neurophysiol., 2013 Oct , 110 (1535-43).

74

Grishin AA et al. Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors.
J. Biol. Chem., 2013 Nov 29 , 288 (34428-42).

75

Shao PP et al. Improved Cav2.2 Channel Inhibitors through a gem-Dimethylsulfone Bioisostere Replacement of a Labile Sulfonamide.
ACS Med Chem Lett, 2013 Nov 14 , 4 (1064-8).

76

Marques JM et al. CRMP2 tethers kainate receptor activity to cytoskeleton dynamics during neuronal maturation.
J. Neurosci., 2013 Nov 13 , 33 (18298-310).

77

Chen R et al. Complex Structures between the N-Type Calcium Channel (CaV2.2) and ω-Conotoxin GVIA Predicted via Molecular Dynamics.
Biochemistry, 2013 May 17 , ().

78

Vivas O et al. PIP₂ hydrolysis is responsible for voltage independent inhibition of CaV2.2 channels in sympathetic neurons.
Biochem. Biophys. Res. Commun., 2013 Mar 8 , 432 (275-80).

79

Almagor L et al. Structural flexibility of CaV1.2 and CaV2.2 I-II proximal linker fragments in solution.
Biophys. J., 2013 Jun 4 , 104 (2392-400).

80

Takai J et al. Laminar shear stress upregulates endothelial Ca2+-activated K+ channels KCa2.3 and KCa3.1 via a Ca2+/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jun 21 , ().

81

Engbers JD et al. Modeling interactions between voltage-gated Ca ( 2+) channels and KCa1.1 channels.
Channels (Austin), 2013 Jul 31 , 7 ().

82

Feldman P et al. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
Neurosci. Lett., 2013 Jul 3 , ().

83

Morales P et al. Contribution of the KCa3.1 channel-calmodulin interactions to the regulation of the KCa3.1 gating process.
J. Gen. Physiol., 2013 Jul , 142 (37-60).

84

Wulff H et al. Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets.
J. Cardiovasc. Pharmacol., 2013 Feb , 61 (102-12).

85

Sousa SR et al. Venom peptides as a rich source of cav2.2 channel blockers.
Toxins (Basel), 2013 Feb , 5 (286-314).

86

Won YJ et al. β-Hydroxybutyrate modulates N-type calcium channels in rat sympathetic neurons by acting as an agonist for the G-protein-coupled receptor FFA3.
J. Neurosci., 2013 Dec 4 , 33 (19314-25).

87

Kyle BD et al. The Large Conductance, Calcium-activated K(+) (BK) Channel is regulated by Cysteine String Protein.
Sci Rep, 2013 Aug 15 , 3 (2447).

88

Mukherjee A et al. Telomeric gene deletion and intrachromosomal amplification in antimony-resistant Leishmania.
Mol. Microbiol., 2013 Apr , 88 (189-202).

89

Bernaldez J et al. A Conus regularis conotoxin with a novel eight-cysteine framework inhibits CaV2.2 channels and displays an anti-nociceptive activity.
Mar Drugs, 2013 Apr , 11 (1188-202).

90

Mallmann RT et al. Tetraspanin-13 modulates voltage-gated CaV2.2 Ca2+ channels.
Sci Rep, 2013 , 3 (1777).

91

Benton DC et al. The relationship between functional inhibition and binding for K(Ca)2 channel blockers.
PLoS ONE, 2013 , 8 (e73328).

92

Jiang YQ et al. Spinal morphine but not ziconotide or gabapentin analgesia is affected by alternative splicing of voltage-gated calcium channel CaV2.2 pre-mRNA.
Mol Pain, 2013 , 9 (67).

93

Brennan SC et al. Fetal calcium regulates branching morphogenesis in the developing human and mouse lung: involvement of voltage-gated calcium channels.
PLoS ONE, 2013 , 8 (e80294).

94

Sousa SR et al. Expression and pharmacology of endogenous Cav channels in SH-SY5Y human neuroblastoma cells.
PLoS ONE, 2013 , 8 (e59293).

95

Alvarez YD et al. The immediately releasable pool of mouse chromaffin cell vesicles is coupled to P/Q-type calcium channels via the synaptic protein interaction site.
PLoS ONE, 2013 , 8 (e54846).

96

Wilson SM et al. Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.
J. Biol. Chem., 2012 Oct 12 , 287 (35065-77).

97

Bravo-Martínez J et al. A novel CaV2.2 channel inhibition by piracetam in peripheral and central neurons.
Exp. Biol. Med. (Maywood), 2012 Oct 1 , 237 (1209-18).

98

Shao PP et al. Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.
J. Med. Chem., 2012 Nov 26 , 55 (9847-55).

99

Brittain JM et al. Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2.
FEBS Lett., 2012 Nov 2 , 586 (3813-8).

100

Swensen AM et al. Characterization of the Substituted N-Triazole Oxindole TROX-1, a Small-Molecule, State-Dependent Inhibitor of Cav2 Calcium Channels.
Mol. Pharmacol., 2012 Mar , 81 (488-97).

101

Tatalovic M et al. Expression of the P/Q (Cav2.1) calcium channel in nodose sensory neurons and arterial baroreceptors.
Neurosci. Lett., 2012 Jun 27 , 520 (38-42).

102

Cuny H et al. γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins.
J. Biol. Chem., 2012 Jul 6 , 287 (23948-57).

103

Marangoudakis S et al. Differential ubiquitination and proteasome regulation of Ca(V)2.2 N-type channel splice isoforms.
J. Neurosci., 2012 Jul 25 , 32 (10365-9).

104

Few AP et al. Asynchronous Ca2+ current conducted by voltage-gated Ca2+ (CaV)-2.1 and CaV2.2 channels and its implications for asynchronous neurotransmitter release.
Proc. Natl. Acad. Sci. U.S.A., 2012 Feb 14 , 109 (E452-60).

105

Chang Y et al. Coenzyme Q10 inhibits the release of glutamate in rat cerebrocortical nerve terminals by suppression of voltage-dependent calcium influx and mitogen-activated protein kinase signaling pathway.
J. Agric. Food Chem., 2012 Dec 5 , 60 (11909-18).

106

Lopez Soto EJ et al. A118G Mu Opioid Receptor polymorphism increases inhibitory effects on CaV2.2 channels.
Neurosci. Lett., 2012 Aug 15 , 523 (190-4).

107

Hernández-Vivanco A et al. Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland.
J. Pharmacol. Exp. Ther., 2012 Aug , 342 (263-72).

108

Huang CY et al. Co-expression of high-voltage-activated ion channels Kv3.4 and Cav1.2 in pioneer axons during pathfinding in the developing rat forebrain.
, 2012 Apr 2 , ().

109

Yarotskyy V et al. Domain III regulates N-type (CaV2.2) calcium channel closing kinetics.
J. Neurophysiol., 2012 Apr , 107 (1942-51).

110

Yang T et al. Distinct RGK GTPases differentially use α1- and auxiliary β-binding-dependent mechanisms to inhibit CaV1.2/CaV2.2 channels.
PLoS ONE, 2012 , 7 (e37079).

111

Piekarz AD et al. CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy.
Mol Pain, 2012 , 8 (54).

112

Rajagopal S et al. Effects of isoflurane on the expressed Cav2.2 currents in Xenopus oocytes depend on the activation of protein kinase Cδ and its phosphorylation sites in the Cav2.2α1 subunits.
Neuroscience, 2011 May 19 , 182 (232-40).

113

Bucci G et al. Inhibition of synaptic transmission and G protein modulation by synthetic CaV2.2 Ca2+ channel peptides.
J. Physiol. (Lond.), 2011 Jul 1 , 589 (3085-101).

114

Brittain JM et al. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.
Nat. Med., 2011 Jul , 17 (822-9).

115

Waithe D et al. {beta}-subunits promote the expression of Cav2.2 channels by reducing their proteasomal degradation.
, 2011 Jan 13 , ().

116

Curtis D et al. Case-case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genes.
Psychiatr. Genet., 2011 Feb , 21 (1-4).

117

Mathews S et al. Uptake and translocation of arsenite by Pteris vittata L.: effects of glycerol, antimonite and silver.
Environ. Pollut., 2011 Dec , 159 (3490-5).

118

Davies JN et al. Bipartite syntaxin 1A interactions mediate CaV2.2 calcium channel regulation.
Biochem. Biophys. Res. Commun., 2011 Aug 5 , 411 (562-8).

119

Dolga AM et al. KCa2 channels activation prevents [Ca2+]i deregulation and reduces neuronal death following glutamate toxicity and cerebral ischemia.
Cell Death Dis, 2011 , 2 (e147).

120

Perez-Reyes E Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels.
Channels (Austin), 2010 Nov-Dec , 4 (453-8).

121

Allen SE et al. The neuronal splicing factor Nova controls alternative splicing in N-type and P-type CaV2 calcium channels.
Channels (Austin), 2010 Nov-Dec , 4 (483-9).

122

Currie KP G protein modulation of CaV2 voltage-gated calcium channels.
Channels (Austin), 2010 Nov-Dec , 4 (497-509).

123

Yarotskyy V et al. Interference between two modulators of N-type (CaV2.2) calcium channel gating demonstrates that omega-conotoxin GVIA disrupts open state gating.
Biochim. Biophys. Acta, 2010 Sep , 1798 (1821-8).

124

Lötsch J et al. Pharmacogenetics of new analgesics.
, 2010 Oct 13 , ().

125

Robinson P et al. Formation of N-type (Cav2.2) voltage-gated calcium channel membrane microdomains: Lipid raft association and clustering.
Cell Calcium, 2010 Oct , 48 (183-94).

126

Finley MF et al. An Integrated Multiassay Approach to the Discovery of Small-Molecule N-Type Voltage-Gated Calcium Channel Antagonists.
, 2010 Nov 4 , ().

127

Mandal S et al. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India.
J. Antimicrob. Chemother., 2010 Mar , 65 (496-507).

128

Vick KA et al. In vivo pharmacological manipulation of small conductance Ca(2+)-activated K(+) channels influences motor behavior, object memory and fear conditioning.
Neuropharmacology, 2010 Mar , 58 (650-9).

129

Wong FK et al. Rab3a interacting molecule (RIM) and the tethering of pre-synaptic transmitter release site-associated CaV2.2 calcium channels.
J. Neurochem., 2010 Jan , 112 (463-73).

130

Yamaguchi M et al. The haplotype of the CACNA1B gene associated with cerebral infarction in a Japanese population.
Hereditas, 2010 Dec , 147 (313-9).

131

Pedrosa E et al. β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network.
J. Neurogenet., 2010 Dec , 24 (182-93).

132

Ohta T et al. Decreased calcium channel currents and facilitated epinephrine release in the Ca2+ channel beta3 subunit-null mice.
Biochem. Biophys. Res. Commun., 2010 Apr 9 , 394 (464-9).

133

Tedford HW et al. Scanning mutagenesis of the I-II loop of the Cav2.2 calcium channel identifies residues Arginine 376 and Valine 416 as molecular determinants of voltage dependent G protein inhibition.
Mol Brain, 2010 , 3 (6).

134

Schlichter LC et al. The Ca2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro.
J Neuroinflammation, 2010 , 7 (4).

135

Barbara G et al. T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids.
J. Neurosci., 2009 Oct 21 , 29 (13106-14).

136

Brittain JM et al. An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels.
J. Biol. Chem., 2009 Nov 6 , 284 (31375-90).

137

Yarotskyy V et al. Open-state occupancy prevents gating charge relaxation of N-type (CaV2.2) calcium channels.
Biophys. J., 2009 Nov 4 , 97 (2446-55).

138

Mitra-Ganguli T et al. Orientation of palmitoylated CaVbeta2a relative to CaV2.2 is critical for slow pathway modulation of N-type Ca2+ current by tachykinin receptor activation.
J. Gen. Physiol., 2009 Nov , 134 (385-96).

139

Lewis BB et al. Cloning and characterization of voltage-gated calcium channel alpha1 subunits in Xenopus laevis during development.
Dev. Dyn., 2009 Nov , 238 (2891-902).

140

Motagally MA et al. Tumour necrosis factor alpha activates nuclear factor kappaB signalling to reduce N-type voltage-gated Ca2+ current in postganglionic sympathetic neurons.
J. Physiol. (Lond.), 2009 Jun 1 , 587 (2623-34).

141

Yarotskyy V et al. omega-conotoxin GVIA alters gating charge movement of N-type (CaV2.2) calcium channels.
J. Neurophysiol., 2009 Jan , 101 (332-40).

142

Dresviannikov AV et al. Determinants of the voltage dependence of G protein modulation within calcium channel beta subunits.
Pflugers Arch., 2009 Feb , 457 (743-56).

143

Smyth LM et al. N-type and P/Q-type calcium channels regulate differentially the release of noradrenaline, ATP and beta-NAD in blood vessels.
Neuropharmacology, 2009 Feb , 56 (368-78).

144

Sankaranarayanan A et al. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Mol. Pharmacol., 2009 Feb , 75 (281-95).

145

Miyamoto N et al. The utilization of gene targeting models during in preclinical study of drug discovery process--example of phenotypic and functional analysis of Cacna1beta gene product.
Curr Pharm Biotechnol, 2009 Feb , 10 (261-7).

146

Wu ZZ et al. Aminopyridines potentiate synaptic and neuromuscular transmission by targeting the voltage-activated calcium channel beta subunit.
J. Biol. Chem., 2009 Dec 25 , 284 (36453-61).

147

Chi XX et al. Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.
J. Cell. Sci., 2009 Dec 1 , 122 (4351-62).

148

Gardezi SR et al. PDLIM5 is not a neuronal CaV2.2 adaptor protein.
Nat. Neurosci., 2009 Aug , 12 (957-8; author reply 958).

149

Sakurai E et al. Upregulation of casein kinase 1epsilon in dorsal root ganglia and spinal cord after mouse spinal nerve injury contributes to neuropathic pain.
Mol Pain, 2009 , 5 (74).

150

Hamdi M et al. Arsenic transport by zebrafish aquaglyceroporins.
BMC Mol. Biol., 2009 , 10 (104).

151

Murakami M et al. Modified sympathetic nerve system activity with overexpression of the voltage-dependent calcium channel beta3 subunit.
J. Biol. Chem., 2008 Sep 5 , 283 (24554-60).

152

Leenders AG et al. The role of MAP1A light chain 2 in synaptic surface retention of Cav2.2 channels in hippocampal neurons.
J. Neurosci., 2008 Oct 29 , 28 (11333-46).

153

Ferron L et al. The stargazin-related protein gamma 7 interacts with the mRNA-binding protein heterogeneous nuclear ribonucleoprotein A2 and regulates the stability of specific mRNAs, including CaV2.2.
J. Neurosci., 2008 Oct 15 , 28 (10604-17).

154

Cino I et al. Spermine biphasically affects N-type calcium channel currents in adult dorsal root ganglion neurons of the rat.
Biochim. Biophys. Acta, 2008 Oct , 1778 (2437-43).

155

Thapliyal A et al. The monomeric G proteins AGS1 and Rhes selectively influence Galphai-dependent signaling to modulate N-type (CaV2.2) calcium channels.
Am. J. Physiol., Cell Physiol., 2008 Nov , 295 (C1417-26).

156

Díaz-Cárdenas AF et al. PMA counteracts G protein actions on CaV2.2 channels in rat sympathetic neurons.
Arch. Biochem. Biophys., 2008 May 1 , 473 (1-7).

157

Buraei Z et al. The separation of antagonist from agonist effects of trisubstituted purines on CaV2.2 (N-type) channels.
J. Neurochem., 2008 May , 105 (1450-61).

158

Su X et al. Role of spinal Cav2.2 and Cav2.1 ion channels in bladder nociception.
J. Urol., 2008 Jun , 179 (2464-9).

159

Dray A Neuropathic pain: emerging treatments.
, 2008 Jul , 101 (48-58).

160

Maharjan M et al. Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani.
Am. J. Trop. Med. Hyg., 2008 Jul , 79 (69-75).

161

Dick IE et al. A modular switch for spatial Ca2+ selectivity in the calmodulin regulation of CaV channels.
Nature, 2008 Feb 14 , 451 (830-4).

162

Zhang JS et al. [Neurons in the corpus callosum of rats: expression of Cav2.2 and their connection]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2008 Feb , 33 (99-102).

163

Ramanathan S et al. D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons through inhibition of Cav2.2 channels.
J. Neurophysiol., 2008 Feb , 99 (442-59).

164

Dai G et al. A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors.
, 2008 Apr , 6 (195-212).

165

Cohen R et al. Reconstitution of depolarization and Ca2+-evoked secretion in Xenopus oocytes monitored by membrane capacitance.
Methods Mol. Biol., 2008 , 440 (269-82).

166

Stackman RW et al. Contextual memory deficits observed in mice overexpressing small conductance Ca2+-activated K+ type 2 (KCa2.2, SK2) channels are caused by an encoding deficit.
Learn. Mem., 2008 , 15 (208-13).

167

Chan AW et al. Resistance of presynaptic CaV2.2 channels to voltage-dependent inactivation: dynamic palmitoylation and voltage sensitivity.
Cell Calcium, 2007 Oct-Nov , 42 (419-25).

168

Chan AW et al. Munc18: a presynaptic transmitter release site N type (CaV2.2) calcium channel interacting protein.
Channels (Austin), 2007 Jan-Feb , 1 (11-20).

169

Li Y et al. The role of 14-3-3 dimerization in its modulation of the CaV2.2 channel.
Channels (Austin), 2007 Jan-Feb , 1 (1-2).

170

Jablonka S et al. Defective Ca2+ channel clustering in axon terminals disturbs excitability in motoneurons in spinal muscular atrophy.
J. Cell Biol., 2007 Oct 8 , 179 (139-49).

171

Llinás RR et al. Gamma-band deficiency and abnormal thalamocortical activity in P/Q-type channel mutant mice.
Proc. Natl. Acad. Sci. U.S.A., 2007 Nov 6 , 104 (17819-24).

172

Sandoval A et al. gamma1-dependent down-regulation of recombinant voltage-gated Ca2+ channels.
Cell. Mol. Neurobiol., 2007 Nov , 27 (901-8).

173

Khanna R et al. A proteomic screen for presynaptic terminal N-type calcium channel (CaV2.2) binding partners.
J. Biochem. Mol. Biol., 2007 May 31 , 40 (302-14).

174

Zaitsev AV et al. P/Q-type, but not N-type, calcium channels mediate GABA release from fast-spiking interneurons to pyramidal cells in rat prefrontal cortex.
J. Neurophysiol., 2007 May , 97 (3567-73).

175

Buraei Z et al. Roscovitine differentially affects CaV2 and Kv channels by binding to the open state.
Neuropharmacology, 2007 Mar , 52 (883-94).

176

Raingo J et al. Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors.
Nat. Neurosci., 2007 Mar , 10 (285-92).

177

Murakami M et al. Modified behavioral characteristics following ablation of the voltage-dependent calcium channel beta3 subunit.
Brain Res., 2007 Jul 30 , 1160 (102-12).

178

Meza U et al. Neurokinin 1 receptors trigger overlapping stimulation and inhibition of CaV2.3 (R-type) calcium channels.
Mol. Pharmacol., 2007 Jan , 71 (284-93).

179

Katsura M et al. Up-regulation of L-type high voltage-gated calcium channel subunits by sustained exposure to 1,4- and 1,5-benzodiazepines in cerebrocortical neurons.
J. Neurochem., 2007 Dec , 103 (2518-28).

180

Sun HS et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J., 2007 Aug 15 , 93 (1175-83).

181

Khanna R et al. The transmitter release-site CaV2.2 channel cluster is linked to an endocytosis coat protein complex.
Eur. J. Neurosci., 2007 Aug , 26 (560-74).

182

Khanna R et al. The presynaptic CaV2.2 channel-transmitter release site core complex.
Eur. J. Neurosci., 2007 Aug , 26 (547-59).

183

Weiss N Alternative splicing of the Cav2.2 subunit: a change in N-type calcium channel activity for which purpose?
J. Physiol. (Lond.), 2007 Apr 15 , 580 (361-2).

184

Cohen R et al. Depolarization-evoked secretion requires two vicinal transmembrane cysteines of syntaxin 1A.
PLoS ONE, 2007 , 2 (e1273).

185

Dray A et al. Arthritis and pain. Future targets to control osteoarthritis pain.
Arthritis Res. Ther., 2007 , 9 (212).

186

Li Y et al. Modulation of inactivation properties of CaV2.2 channels by 14-3-3 proteins.
Neuron, 2006 Sep 21 , 51 (755-71).

187

Benjamin ER et al. Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR.
Biochem. Pharmacol., 2006 Sep 14 , 72 (770-82).

188

Goo YS et al. Ca2+ enhances U-type inactivation of N-type (CaV2.2) calcium current in rat sympathetic neurons.
J. Neurophysiol., 2006 Sep , 96 (1075-83).

189

Berkefeld H et al. BKCa-Cav channel complexes mediate rapid and localized Ca2+-activated K+ signaling.
Science, 2006 Oct 27 , 314 (615-20).

190

Castiglioni AJ et al. Alternative splicing in the C-terminus of CaV2.2 controls expression and gating of N-type calcium channels.
J. Physiol. (Lond.), 2006 Oct 1 , 576 (119-34).

191

Yang SN et al. The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology.
Endocr. Rev., 2006 Oct , 27 (621-76).

192

Vinet J et al. Expression pattern of voltage-dependent calcium channel subunits in hippocampal inhibitory neurons in mice.
Neuroscience, 2006 Nov 17 , 143 (189-212).

193

Sandoval A et al. Two PEST-like motifs regulate Ca2+/calpain-mediated cleavage of the CaVbeta3 subunit and provide important determinants for neuronal Ca2+ channel activity.
Eur. J. Neurosci., 2006 May , 23 (2311-20).

194

Pagani MR et al. Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals.
J. Neurosci., 2006 Mar 8 , 26 (2661-72).

195

Grolleau F et al. Indirect activation of neuronal noncapacitative Ca2+ entry is the final step involved in the neurotoxic effect of Tityus serrulatus scorpion beta-toxin.
Eur. J. Neurosci., 2006 Mar , 23 (1465-78).

196

Sun L et al. Transmitter release face Ca2+ channel clusters persist at isolated presynaptic terminals.
Eur. J. Neurosci., 2006 Mar , 23 (1391-6).

197

Khanna R et al. N type Ca2+ channels and RIM scaffold protein covary at the presynaptic transmitter release face but are components of independent protein complexes.
Neuroscience, 2006 Jul 21 , 140 (1201-8).

198

Gao L et al. CaMKII-independent effects of KN93 and its inactive analog KN92: reversible inhibition of L-type calcium channels.
Biochem. Biophys. Res. Commun., 2006 Jul 14 , 345 (1606-10).

199

Partridge JG et al. Phosducin and phosducin-like protein attenuate G-protein-coupled receptor-mediated inhibition of voltage-gated calcium channels in rat sympathetic neurons.
Mol. Pharmacol., 2006 Jul , 70 (90-100).

200

Srivastava S et al. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.
Mol. Biol. Cell, 2006 Jan , 17 (146-54).

201

Bugianesi RM et al. A cell-sparing electric field stimulation technique for high-throughput screening of voltage-gated ion channels.
, 2006 Feb , 4 (21-35).

202

McDavid S et al. G-proteins modulate cumulative inactivation of N-type (Cav2.2) calcium channels.
J. Neurosci., 2006 Dec 20 , 26 (13373-83).

203

Pardo NE et al. Acetylcholine release at neuromuscular junctions of adult tottering mice is controlled by N-(cav2.2) and R-type (cav2.3) but not L-type (cav1.2) Ca2+ channels.
J. Pharmacol. Exp. Ther., 2006 Dec , 319 (1009-20).

204

Schenning M et al. Glycerotoxin stimulates neurotransmitter release from N-type Ca2+ channel expressing neurons.
J. Neurochem., 2006 Aug , 98 (894-904).

205

Szabo Z et al. Role of the synprint site in presynaptic targeting of the calcium channel CaV2.2 in hippocampal neurons.
Eur. J. Neurosci., 2006 Aug , 24 (709-18).

206

Kaja S et al. Compensatory contribution of Cav2.3 channels to acetylcholine release at the neuromuscular junction of tottering mice.
J. Neurophysiol., 2006 Apr , 95 (2698-704).

207

Martin-Moutot N et al. Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome.
Neurobiol. Dis., 2006 Apr , 22 (57-63).

208

Khanna R et al. Long splice variant N type calcium channels are clustered at presynaptic transmitter release sites without modular adaptor proteins.
Neuroscience, 2006 , 138 (1115-25).

209

Buraei Z et al. Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine.
Biophys. J., 2005 Sep , 89 (1681-91).

210

Goldberg JA et al. Control of spontaneous firing patterns by the selective coupling of calcium currents to calcium-activated potassium currents in striatal cholinergic interneurons.
J. Neurosci., 2005 Nov 2 , 25 (10230-8).

211

Helton TD et al. Neuronal L-type calcium channels open quickly and are inhibited slowly.
J. Neurosci., 2005 Nov 2 , 25 (10247-51).

212

Agler HL et al. G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels.
Neuron, 2005 Jun 16 , 46 (891-904).

213

Leroy J et al. Interaction via a key tryptophan in the I-II linker of N-type calcium channels is required for beta1 but not for palmitoylated beta2, implicating an additional binding site in the regulation of channel voltage-dependent properties.
J. Neurosci., 2005 Jul 27 , 25 (6984-96).

214

Richman RW et al. RGS12 interacts with the SNARE-binding region of the Cav2.2 calcium channel.
J. Biol. Chem., 2005 Jan 14 , 280 (1521-8).

215

Yang SN et al. Beta-cell CaV channel regulation in physiology and pathophysiology.
Am. J. Physiol. Endocrinol. Metab., 2005 Jan , 288 (E16-28).

216

Dekker LV et al. Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells.
Eur. J. Pharmacol., 2005 Dec 28 , 528 (52-8).

217

Tuteja D et al. Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes.
Am. J. Physiol. Heart Circ. Physiol., 2005 Dec , 289 (H2714-23).

218

Winquist RJ et al. Use-dependent blockade of Cav2.2 voltage-gated calcium channels for neuropathic pain.
Biochem. Pharmacol., 2005 Aug 15 , 70 (489-99).

219

Wada T et al. Effects of calmodulin and Ca2+ channel blockers on omega-conotoxin GVIA binding to crude membranes from alpha1B subunit (Cav2.2) expressed BHK cells and mice brain lacking the alpha1B subunits.
Neurochem. Res., 2005 Aug , 30 (1045-54).

220

Ichida S et al. Characteristics of omega-conotoxin GVI A and MVIIC binding to Cav 2.1 and Cav 2.2 channels captured by anti-Ca2+ channel peptide antibodies.
Neurochem. Res., 2005 Apr , 30 (457-66).

221

Vigh J et al. L-type calcium channels mediate transmitter release in isolated, wide-field retinal amacrine cells.
Vis. Neurosci., 2004 Mar-Apr , 21 (129-34).

222

Kim MJ et al. Immunohistochemical study of the distribution of neuronal voltage-gated calcium channels in the nNOS knock-out mouse cerebellum.
Neurosci. Lett., 2004 Oct 7 , 369 (39-43).

223

Harkins AB et al. Deletion of the synaptic protein interaction site of the N-type (CaV2.2) calcium channel inhibits secretion in mouse pheochromocytoma cells.
Proc. Natl. Acad. Sci. U.S.A., 2004 Oct 19 , 101 (15219-24).

224

Tedford HW et al. Scanning mutagenesis of omega-atracotoxin-Hv1a reveals a spatially restricted epitope that confers selective activity against insect calcium channels.
J. Biol. Chem., 2004 Oct 15 , 279 (44133-40).

225

Scheuber A et al. Presynaptic Cav2.1 and Cav2.2 differentially influence release dynamics at hippocampal excitatory synapses.
J. Neurosci., 2004 Nov 17 , 24 (10402-9).

226

Cabrera-Vera TM et al. RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons.
Proc. Natl. Acad. Sci. U.S.A., 2004 Nov 16 , 101 (16339-44).

227

Lin Y et al. Alternative splicing in the voltage-sensing region of N-Type CaV2.2 channels modulates channel kinetics.
J. Neurophysiol., 2004 Nov , 92 (2820-30).

228

D'Ascenzo M et al. Electrophysiological and molecular evidence of L-(Cav1), N- (Cav2.2), and R- (Cav2.3) type Ca2+ channels in rat cortical astrocytes.
Glia, 2004 Mar , 45 (354-63).

229

Scamps F et al. Activation of P-type calcium channel regulates a unique thapsigargin-sensitive calcium pool in embryonic motoneurons.
Eur. J. Neurosci., 2004 Feb , 19 (977-82).

230

Mould J et al. The alpha2delta auxiliary subunit reduces affinity of omega-conotoxins for recombinant N-type (Cav2.2) calcium channels.
J. Biol. Chem., 2004 Aug 13 , 279 (34705-14).

231

Thaler C et al. Cumulative inactivation of N-type CaV2.2 calcium channels modified by alternative splicing.
Proc. Natl. Acad. Sci. U.S.A., 2004 Apr 13 , 101 (5675-9).

232

Ebersberger A et al. Effects of N-, P/Q- and L-type calcium channel blockers on nociceptive neurones of the trigeminal nucleus with input from the dura.
Cephalalgia, 2004 Apr , 24 (250-61).

233

Yasuda T et al. Overexpressed Ca(v)beta3 inhibits N-type (Cav2.2) calcium channel currents through a hyperpolarizing shift of ultra-slow and closed-state inactivation.
J. Gen. Physiol., 2004 Apr , 123 (401-16).

234

Richman RW et al. Mapping of RGS12-Cav2.2 channel interaction.
Meth. Enzymol., 2004 , 390 (224-39).

235

Liang H et al. Unified mechanisms of Ca2+ regulation across the Ca2+ channel family.
Neuron, 2003 Sep 11 , 39 (951-60).

236

Hajela RK et al. Comparative effects of methylmercury and Hg(2+) on human neuronal N- and R-type high-voltage activated calcium channels transiently expressed in human embryonic kidney 293 cells.
J. Pharmacol. Exp. Ther., 2003 Sep , 306 (1129-36).

237

Harkins AB et al. Expression of recombinant calcium channels support secretion in a mouse pheochromocytoma cell line.
J. Neurophysiol., 2003 Oct , 90 (2325-33).

238

Cantí C et al. CaVbeta subunit-mediated up-regulation of CaV2.2 currents triggered by D2 dopamine receptor activation.
Neuropharmacology, 2003 Nov , 45 (814-27).

239

Agler HL et al. Custom distinctions in the interaction of G-protein beta subunits with N-type (CaV2.2) versus P/Q-type (CaV2.1) calcium channels.
J. Gen. Physiol., 2003 Jun , 121 (495-510).

240

Beuckmann CT et al. N-type calcium channel alpha1B subunit (Cav2.2) knock-out mice display hyperactivity and vigilance state differences.
J. Neurosci., 2003 Jul 30 , 23 (6793-7).

241

Carlson AE et al. CatSper1 required for evoked Ca2+ entry and control of flagellar function in sperm.
Proc. Natl. Acad. Sci. U.S.A., 2003 Dec 9 , 100 (14864-8).

242

Hallworth NE et al. Apamin-sensitive small conductance calcium-activated potassium channels, through their selective coupling to voltage-gated calcium channels, are critical determinants of the precision, pace, and pattern of action potential generation in rat subthalamic nu
J. Neurosci., 2003 Aug 20 , 23 (7525-42).

243

Bertaso F et al. Mechanism of action of Gq to inhibit G beta gamma modulation of CaV2.2 calcium channels: probed by the use of receptor-G alpha tandems.
Mol. Pharmacol., 2003 Apr , 63 (832-43).

244

Dave JR et al. Down regulation of sodium channel Na(v)1.1 expression by veratridine and its reversal by a novel sodium channel blocker, RS100642, in primary neuronal cultures.
, 2003 , 5 (213-20).

245

Lubec G et al. RNA microarray analysis of channels and transporters in normal and fetal Down syndrome (trisomy 21) brain.
J. Neural Transm. Suppl., 2003 , (215-24).

246

Kokic M et al. Synthesis and in vitro and in vivo evaluation of [11C]methyl-BIII277CL for imaging the PCP-binding site of the NMDA receptor by pet.
J. Recept. Signal Transduct. Res., 2002 Feb-Nov , 22 (123-39).

247

Zamponi GW et al. Modulating modulation: crosstalk between regulatory pathways of presynaptic calcium channels.
Mol. Interv., 2002 Dec , 2 (476-8).

248

De Laet A et al. Immunohistochemical localization of voltage-activated calcium channels in the rat oesophagus.
Neurogastroenterol. Motil., 2002 Apr , 14 (173-81).

249

Raghib A et al. Dominant-negative synthesis suppression of voltage-gated calcium channel Cav2.2 induced by truncated constructs.
J. Neurosci., 2001 Nov 1 , 21 (8495-504).

250

Stephens GJ et al. The Cav2.1/alpha1A (P/Q-type) voltage-dependent calcium channel mediates inhibitory neurotransmission onto mouse cerebellar Purkinje cells.
Eur. J. Neurosci., 2001 May , 13 (1902-12).

251

Scholze A et al. Functional expression and characterization of a voltage-gated CaV1.3 (alpha1D) calcium channel subunit from an insulin-secreting cell line.
Mol. Endocrinol., 2001 Jul , 15 (1211-21).

252

Joux N et al. High voltage-activated Ca2+ currents in rat supraoptic neurones: biophysical properties and expression of the various channel alpha1 subunits.
J. Neuroendocrinol., 2001 Jul , 13 (638-49).

253

Rolf MG et al. Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP.
Thromb. Haemost., 2001 Feb , 85 (303-8).

254

Herlitze S et al. Allosteric modulation of Ca2+ channels by G proteins, voltage-dependent facilitation, protein kinase C, and Ca(v)beta subunits.
Proc. Natl. Acad. Sci. U.S.A., 2001 Apr 10 , 98 (4699-704).

255

Wennemuth G et al. CaV2.2 and CaV2.3 (N- and R-type) Ca2+ channels in depolarization-evoked entry of Ca2+ into mouse sperm.
J. Biol. Chem., 2000 Jul 14 , 275 (21210-7).

256

Carter AJ et al. Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL.
Proc. Natl. Acad. Sci. U.S.A., 2000 Apr 25 , 97 (4944-9).

257

BIII 277CL. BIII 277, BIII 281CL.
Drugs R D, 1999 Jan , 1 (18-9).

258

Yamazaki K et al. Locations of human genes for alpha 1A, alpha 1B, and alpha 1E calcium channels determined by radiation hybrid mapping.
J. Hered., 1998 May-Jun , 89 (269-71).

259

Grauert M et al. N-methyl-D-aspartate receptor channel block by the enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL.
J. Pharmacol. Exp. Ther., 1998 May , 285 (767-76).

260

Sangameswaran L et al. A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia.
J. Biol. Chem., 1997 Jun 6 , 272 (14805-9).

261

Diriong S et al. Chromosomal localization of the human genes for alpha 1A, alpha 1B, and alpha 1E voltage-dependent Ca2+ channel subunits.
Genomics, 1995 Dec 10 , 30 (605-9).

262

Carter AJ et al. BIII 277 CL is a potent and specific ion-channel blocker of the NMDA receptor-channel complex.
J. Pharmacol. Exp. Ther., 1995 Dec , 275 (1382-9).

263

Malo MS et al. Targeted gene walking by low stringency polymerase chain reaction: assignment of a putative human brain sodium channel gene (SCN3A) to chromosome 2q24-31.
Proc. Natl. Acad. Sci. U.S.A., 1994 Apr 12 , 91 (2975-9).

264

Wakamori M et al. Distinctive functional properties of the neuronal BII (class E) calcium channel.
Recept. Channels, 1994 , 2 (303-14).

265

Fujita Y et al. Primary structure and functional expression of the omega-conotoxin-sensitive N-type calcium channel from rabbit brain.
Neuron, 1993 Apr , 10 (585-98).